about
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients ...
Read More
3.76
-0.40
(-9.62%)
175.4K
XNAS Volume
XNAS 19 Aug, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Cingulate Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..